The Thyroid Receptor Antibody (TRAb) test is an essential diagnostic tool for detecting and managing autoimmune thyroid diseases, particularly Graves' disease and Hashimoto's disease. It measures autoantibodies targeting the thyroid-stimulating hormone receptor (TSHR), which can disrupt normal thyroid function. The TRAb test is crucial for differentiating causes of thyrotoxicosis, diagnosing Graves' disease, and assessing neonatal thyrotoxicosis risk in pregnant women with a history of Graves' disease. It is especially useful when clinical presentations are ambiguous or when other diagnostic methods are unsuitable. The test employs a quantitative electrochemiluminescent immunoassay (ECLIA) to detect TRAb levels, offering high sensitivity and specificity. Clinically, it aids in therapy selection, prognostic predictions for Graves' ophthalmopathy and pretibial myxedema, and risk prediction for fetal and neonatal thyrotoxicosis. Proper specimen handling and storage are vital for accurate results, with frozen specimens preferred for long-term storage. Overall, the TRAb test is invaluable in personalized patient care for autoimmune thyroid conditions.
The Thyroid Receptor Antibody (TRAb) test is an essential diagnostic tool for detecting and managing autoimmune thyroid diseases, particularly Graves' disease and Hashimoto's disease. It measures autoantibodies targeting the thyroid-stimulating hormone receptor (TSHR), which can disrupt normal thyroid function. The TRAb test is crucial for differentiating causes of thyrotoxicosis, diagnosing Graves' disease, and assessing neonatal thyrotoxicosis risk in pregnant women with a history of Graves' disease. It is especially useful when clinical presentations are ambiguous or when other diagnostic methods are unsuitable. The test employs a quantitative electrochemiluminescent immunoassay (ECLIA) to detect TRAb levels, offering high sensitivity and specificity. Clinically, it aids in therapy selection, prognostic predictions for Graves' ophthalmopathy and pretibial myxedema, and risk prediction for fetal and neonatal thyrotoxicosis. Proper specimen handling and storage are vital for accurate results, with frozen specimens preferred for long-term storage. Overall, the TRAb test is invaluable in personalized patient care for autoimmune thyroid conditions.
The lowest price from the last 30 days: £180
Awaiting result:
5 days
Collect material:
Blood
Prepare:
The TRAb test is vital for diagnosing and managing autoimmune thyroid diseases. It measures autoantibodies targeting the TSH receptor, aiding in:
- Differential Diagnosis: Helps distinguish causes of thyrotoxicosis, such as Graves' disease.
- Graves' Disease Diagnosis: Elevated TRAb levels indicate this condition.
- Neonatal Risk Assessment: Evaluates risk of neonatal thyrotoxicosis in pregnant women with Graves' history.
- Gestational Thyrotoxicosis: Differentiates it from Graves' disease.
Performed via electrochemiluminescent immunoassay, it offers high sensitivity and specificity, guiding therapy and prognosis.
The Thyroid Receptor Antibody (TRAb) test is vital for diagnosing autoimmune thyroid diseases like Graves' and Hashimoto's. It measures autoantibodies targeting the thyroid-stimulating hormone receptor, affecting thyroid function. Key uses include:
- Differential Diagnosis of Thyrotoxicosis: Helps distinguish causes like Graves' disease.
- Diagnosing Graves' Disease: Elevated TRAb levels indicate this condition.
- Neonatal Thyrotoxicosis Risk: Assesses risk in pregnant women with Graves' history.
- Gestational Thyrotoxicosis: Differentiates from Graves' disease.
The test's sensitivity and specificity aid in therapy selection and prognostic predictions, enhancing patient care.
Understanding test results is crucial for effective management of autoimmune thyroid diseases. The Thyroid Receptor Antibody (TRAb) test provides valuable insights:
- Differential Diagnosis: Helps distinguish between causes of thyrotoxicosis, such as Graves' disease and gestational thyrotoxicosis.
- Graves' Disease Diagnosis: Elevated TRAb levels indicate Graves' disease, even with normal thyroid function tests.
- Neonatal Risk Assessment: In pregnant women, high TRAb levels suggest a risk of neonatal thyrotoxicosis.
- Therapy and Prognosis: Guides treatment decisions and predicts complications like Graves' ophthalmopathy.
Accurate interpretation ensures optimal patient care.
The lowest price from the last 30 days: £180
What is GetLabTest.com?
How do I get started with GetLabTest.com?
What diseases can GetLabTest.com detect?
How do I prepare for testing with GetLabTest.com?
Can I speak with a doctor about my results?
Is testing with GetLabTest.com covered by insurance?
How long does it take to receive the test results?
Can I access my test results online?
Is my personal information kept confidential?
What if I have questions or concerns about my test results?